Jacobs Levy Equity Management
CORZ icon

Jacobs Levy Equity Management’s Core Scientific CORZ Stock Holding History

Jacobs Levy Equity Management’s Portfolio CORZ Stock Details CORZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.75M Sell
68,550
-151,118
-69% -$3.56M 0.01% 621
2026
Q1 		$3.29M Sell
219,668
-610,724
-74% -$10.4M 0.01% 498
2025
Q4 		$12.1M Buy
+830,392
New +$14.5M 0.05% 275

Other funds holding CORZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SA
Situational Awareness San Francisco, California $20.2B AUM 612.59% 1-Year Est. Return
JCAM
Jericho Capital Asset Management New York $12.1B AUM 109.57% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VARA
Value Aligned Research Advisors Princeton, New Jersey $40.1B AUM 376.19% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return

Jacobs Levy Equity Management's CORZ Position: Q2 2026 in Review

Jacobs Levy Equity Management reduced its Core Scientific (CORZ) stake by 69% in Q2 2026, selling an estimated $3.56M and leaving 68,550 shares worth $1.75M. The position accounts for 0.01% of the portfolio, ranked #621.

Jacobs Levy Equity Management first reported a position in CORZ in Q4 2025 and has held it in 3 quarters since. The position peaked at $12.1M in Q4 2025. 412 funds tracked by Wall St. Rank hold CORZ as of Q2 2026.

  • Jacobs Levy Equity Management held 68,550 shares of Core Scientific worth $1.75M as of Q2 2026.
  • Jacobs Levy Equity Management sold 151,118 Core Scientific shares in Q2 2026, an estimated $3.56M.
  • Core Scientific made up 0.01% of Jacobs Levy Equity Management's portfolio in Q2 2026, its #621 holding.
  • Jacobs Levy Equity Management first reported a position in Core Scientific in Q4 2025 and has held it in 3 quarters since.
  • Jacobs Levy Equity Management's Core Scientific position peaked at $12.1M in Q4 2025.
  • 412 funds tracked by Wall St. Rank held Core Scientific as of Q2 2026.

Based on Jacobs Levy Equity Management's 13F filing for Q2 2026, filed 14 Aug 2026.